By Melissa Singer Weiss, Principal
Apply the same diligence\and discipline to your career decisions that you bring to advancing science or proving an investment thesis.
Over my decade in executive search and nearly two steeped in the life sciences industry, I have seen too many talented leaders make what seemed like the perfect move, only to discover the fit was not what they expected. Their career hypothesis was disproven.
Two recent conversations reinforced this. A renowned scientist joined an early-stage biotech based on a colleague’s endorsement and a compelling deck, but skipped his own due diligence. A celebrated CBO/CFO trusted a board’s shiny reputation over her instincts and allowed a rushed process to drive her choice.
Both are brilliant and experienced, but missed one critical step: applying the same rigor to their career transitions that they use to guide scientific or investments decisions.
The cost is real. Harvard Business Review estimates that a poor executive career move can cost $500K–$2M in lost earnings and opportunity over five years.
So how do you test your next career hypothesis?
1️⃣ Interrogate the Data.
Request data packages, timelines, and cap tables (even if not offered). Pressure-test assumptions, competitive positioning, and regulatory strategy. Do not assume big names equal rigor.
2️⃣ Diligence the People and Culture.
Conduct backchannel references with trusted contacts (including Executive Search!) to validate initial chemistry with the team. Do these leaders empower, mentor, and collaborate under pressure? Are ELT and BOD stakeholders are aligned? Will these relationships open doors when setbacks inevitably occur? Take note of repeat investment and followership, those actions speak louder than words.
3️⃣ Align the Vision.
Ask whether this role truly advances your goals and whether it positions you for the next one. Sometimes, a lateral move that broadens your scope beats a linear promotion.
4️⃣ Control the Process.
Be transparent about timelines and options. Sophisticated leaders respect an informed, deliberate evaluation. Artificial urgency often portends how internal decisions get made.
Career setbacks happen and can offer valuable lessons for the future. But repeated missteps can raise questions about judgment and ability to learn from mistakes, salient qualities assessed in leadership appointments.
Life sciences leaders bring extraordinary rigor to advancing science, patient impact, and creating value for shareholders — yet too often abandon that discipline when evaluating their own paths.
It may seem obvious, but treating your next transition like a scientific hypothesis — testing, validating, and refining — can protect not just your earnings, but your reputation, relationships, and long-term trajectory.
In executive search, my role isn’t just to place leaders for our clients — it’s to advise them. The most successful transitions happen when leaders approach their careers with the same evidence-based mindset that drives innovation itself.
